Stock listing
Munich:DB0 Q32 Bio Inc. Aktie
German listing (Munich) of Q32 Bio Inc. · home listing NASDAQ:QTTB
Follow Q32 Bio Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:QTTB
$8.91 USD +0.04 (+0.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:QTTB
- Day range
- $8.53 – $8.98 USDOct 30, 2026
- Volume
- 268,080 sharesOct 30, 2026
- Market cap
- $265.2M USDAt the close on Oct 30, 2026 · price × 29.77M shares outstanding
- 52-week range
- $1.91 – $23.57 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $7.48M USDMedian day 559,743 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:QTTB · Home | $8.91 USD | +0.04 (+0.5%) | 268,080 | $8.87 | $8.98 | $8.53 | $8.87 | Close on Oct 30, 2026 |
| LSE:0T6G | $8.685 USD | +0.095 (+1.1%) | 226 | $8.52 | $8.77 | $8.40 | $8.59 | Close on Oct 27, 2026 |
| Frankfurt:DB0 | €7.425 EUR | +0.345 (+4.9%) | — | €7.425 | €7.425 | €7.425 | €7.08 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:QTTB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.91 | +0.04 | +0.5% | $8.87 | $8.98 | $8.53 | 268,080 | |
| $8.87 | -0.19 | -2.1% | $9.20 | $9.349 | $8.86 | 317,788 | |
| $9.06 | +0.35 | +4.0% | $8.65 | $9.11 | $8.51 | 409,200 | |
| $8.71 | +0.26 | +3.1% | $8.52 | $8.82 | $8.429 | 692,575 | |
| $8.45 | -0.20 | -2.3% | $8.60 | $8.825 | $8.39 | 563,686 | |
| $8.65 | -0.15 | -1.7% | $8.80 | $8.835 | $8.30 | 404,000 | |
| $8.80 | +0.13 | +1.5% | $8.67 | $9.01 | $8.60 | 363,600 | |
| $8.67 | +0.05 | +0.6% | $8.62 | $8.81 | $8.55 | 322,100 | |
| $8.62 | +0.83 | +10.7% | $7.79 | $8.84 | $7.79 | 506,100 | |
| $7.79 | +0.27 | +3.6% | $7.52 | $7.94 | $7.52 | 609,900 | |
| $7.52 | -0.25 | -3.2% | $7.82 | $7.82 | $7.28 | 678,000 | |
| $7.77 | -0.24 | -3.0% | $8.01 | $8.29 | $7.72 | 625,300 | |
| $8.01 | -0.05 | -0.6% | $7.93 | $8.30 | $7.72 | 889,300 | |
| $8.06 | -0.68 | -7.8% | $8.69 | $8.69 | $7.89 | 719,800 | |
| $8.74 | +0.40 | +4.8% | $8.64 | $9.155 | $8.44 | 682,300 | |
| $8.34 | +0.25 | +3.1% | $8.125 | $8.46 | $7.94 | 854,600 | |
| $8.09 | +0.10 | +1.3% | $7.94 | $8.12 | $7.62 | 859,600 | |
| $7.99 | -0.12 | -1.5% | $8.00 | $8.07 | $7.83 | 569,600 | |
| $8.11 | -0.26 | -3.1% | $8.32 | $8.36 | $7.80 | 678,400 | |
| $8.37 | +0.14 | +1.7% | $8.09 | $8.56 | $7.81 | 954,800 | |
| $8.23 | -0.02 | -0.2% | $8.35 | $9.11 | $8.17 | 2,097,000 | |
| $8.25 | -0.02 | -0.2% | $8.36 | $8.85 | $7.75 | 3,085,900 | |
| $8.27 | -1.26 | -13.2% | $10.40 | $10.40 | $7.878 | 5,250,500 | |
| $9.53 | +0.30 | +3.3% | $9.32 | $9.665 | $9.164 | 914,800 | |
| $9.23 | +0.46 | +5.2% | $9.21 | $9.445 | $8.77 | 1,004,900 | |
| $8.77 | -0.45 | -4.9% | $9.20 | $9.20 | $8.74 | 514,800 | |
| $9.22 | -0.34 | -3.6% | $9.51 | $9.55 | $9.05 | 1,075,000 | |
| $9.56 | -1.01 | -9.6% | $10.58 | $10.58 | $9.50 | 828,400 | |
| $10.57 | +0.10 | +1.0% | $10.60 | $10.99 | $10.53 | 387,200 | |
| $10.47 | -0.07 | -0.7% | $10.57 | $10.75 | $10.30 | 359,000 | |
| $10.54 | -0.32 | -2.9% | $10.84 | $10.97 | $10.46 | 972,300 | |
| $10.86 | -0.12 | -1.1% | $11.14 | $11.17 | $10.69 | 384,000 | |
| $10.98 | -0.19 | -1.7% | $11.17 | $11.41 | $10.87 | 504,900 | |
| $11.17 | +0.26 | +2.4% | $10.77 | $11.29 | $10.51 | 602,500 | |
| $10.91 | -0.19 | -1.7% | $10.96 | $11.28 | $10.63 | 870,600 | |
| $11.10 | +0.38 | +3.5% | $10.82 | $11.27 | $10.45 | 1,824,300 | |
| $10.72 | -0.42 | -3.8% | $11.00 | $11.08 | $10.54 | 937,600 | |
| $11.14 | -0.55 | -4.7% | $11.61 | $11.95 | $11.07 | 488,700 | |
| $11.69 | -0.30 | -2.5% | $12.00 | $12.00 | $11.57 | 592,900 | |
| $11.99 | -0.81 | -6.3% | $12.60 | $12.70 | $11.50 | 851,500 | |
| $12.80 | -0.79 | -5.8% | $13.52 | $13.59 | $12.74 | 491,500 | |
| $13.59 | -0.77 | -5.4% | $14.42 | $14.55 | $13.35 | 434,600 | |
| $14.36 | -0.51 | -3.4% | $14.77 | $14.77 | $14.18 | 331,400 | |
| $14.87 | -0.16 | -1.1% | $14.85 | $15.32 | $14.75 | 349,900 | |
| $15.03 | -1.12 | -6.9% | $15.91 | $16.25 | $14.92 | 353,400 | |
| $16.15 | -0.03 | -0.2% | $16.08 | $16.30 | $15.93 | 203,300 | |
| $16.18 | -0.14 | -0.9% | $16.13 | $16.52 | $15.80 | 327,100 | |
| $16.32 | -0.04 | -0.2% | $16.36 | $16.98 | $16.06 | 599,089 | |
| $16.36 | +0.39 | +2.4% | $16.50 | $16.66 | $15.50 | 691,058 | |
| $15.97 | +0.11 | +0.7% | $15.89 | $16.29 | $15.72 | 341,400 | |
| $15.86 | +0.02 | +0.1% | $15.80 | $16.15 | $15.51 | 389,100 | |
| $15.84 | +0.55 | +3.6% | $15.56 | $15.93 | $15.25 | 266,900 | |
| $15.29 | -0.66 | -4.1% | $15.65 | $16.04 | $15.04 | 319,400 | |
| $15.95 | +0.80 | +5.3% | $15.18 | $16.05 | $15.18 | 301,100 | |
| $15.15 | -0.22 | -1.4% | $15.45 | $15.47 | $14.93 | 313,300 | |
| $15.37 | 0.00 | 0.0% | $15.47 | $15.80 | $15.19 | 182,400 | |
| $15.37 | -0.04 | -0.3% | $15.33 | $15.60 | $15.11 | 270,000 | |
| $15.41 | -0.26 | -1.7% | $15.67 | $15.77 | $14.79 | 614,794 | |
| $15.67 | +0.07 | +0.4% | $15.30 | $16.69 | $15.28 | 439,597 | |
| $15.60 | -0.60 | -3.7% | $16.58 | $16.58 | $15.41 | 513,500 | |
| $16.20 | -0.29 | -1.8% | $16.47 | $16.96 | $16.02 | 604,400 | |
| $16.49 | +0.335 | +2.1% | $16.15 | $16.95 | $15.73 | 651,400 | |
| $16.16 | +0.99 | +6.5% | $15.15 | $16.24 | $15.02 | 727,800 | |
| $15.17 | -0.515 | -3.3% | $15.50 | $15.73 | $14.68 | 328,900 | |
| $15.68 | +0.12 | +0.8% | $15.73 | $15.99 | $15.00 | 387,100 | |
| $15.56 | +0.92 | +6.3% | $14.61 | $15.76 | $14.39 | 555,800 |
- Ticker
- Munich:DB0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Sep 30, 2026
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
Latest deck · Sep 30, 2026
EADV Congress 2026
Conference · 16 slides
Latest news
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
Sep 30, 2026
Closed $8.27 (-13.2%) on Sep 30, 2026
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
Sep 21, 2026
Closed $10.47 (-0.7%) on Sep 21, 2026
Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
Sep 14, 2026
Closed $10.91 (-1.7%) on Sep 14, 2026
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 5, 2026
Closed $16.49 (+2.1%) on Aug 5, 2026
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants
Jul 14, 2026
Closed $15.70 (-15.0%) on Jul 15, 2026
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jul 13, 2026
Closed $18.46 (-13.7%) on Jul 14, 2026
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
Jul 13, 2026
Closed $21.38 (+90.7%) on Jul 13, 2026
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
Jul 10, 2026
Closed $21.38 (+90.7%) on Jul 13, 2026
Q32 Bio Announces $55 Million Private Placement Financing
May 27, 2026
Closed $12.85 (+81.2%) on May 27, 2026
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 5, 2026
Closed $5.14 (+2.0%) on May 5, 2026
Financings
Public offering of common stock and pre-funded warrants
Aug 5, 2026
Closed: US$200M raised · US$18.25 a share · Morgan Stanley +4
Dealers: Morgan Stanley (co-lead), Jefferies (co-lead), Cantor (co-lead), Oppenheimer & Co., H.C. Wainwright & Co.
Use of proceeds: With existing cash, fund operations through topline Phase 3 results of the planned registration-directed bempikibart program in severe or very severe AA
Announced Jul 13, 2026 · Update Jul 15, 2026 · Closed Aug 5, 2026
Decks
EADV Congress 2026
Conference · 16 slides · Sep 30, 2026
Technical Presentation (July 2026)
Technical · 24 slides · Jul 13, 2026
American Academy of Dermatology Late Breaker Session 2025
Conference · 16 slides · Mar 8, 2025
Investor Presentation (January 2025)
Investor deck · 34 slides · Jan 13, 2025
Q32 Bio Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 109 in all · newest Sep 30, 2026 · oldest 2020
- Decks
- 7 decks · latest Sep 30, 2026
Where Q32 Bio Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:QTTB · Home listing | NASDAQ | United States | USD |
| gettex:DB0 | gettex | Germany | EUR |
| Lang & Schwarz:A4ZZ0Z | Lang & Schwarz | Germany | EUR |
| LSE:0T6G | LSE | United Kingdom | USD |
| BOATS:QTTB | BOATS | United States | USD |
| Dusseldorf:DB0 | Dusseldorf | Germany | EUR |
| Frankfurt:DB0 | Frankfurt | Germany | EUR |
| Munich:DB0 · This page | Munich | Germany | EUR |
| Stuttgart:DB0 | Stuttgart | Germany | EUR |
| Tradegate:DB0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Q32 Bio Inc.